Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (30409) 30409
Book Review (6279) 6279
Patent (3346) 3346
Publication (1953) 1953
Newsletter (631) 631
Newspaper Article (508) 508
Book Chapter (223) 223
Magazine Article (222) 222
Conference Proceeding (172) 172
Trade Publication Article (68) 68
Book / eBook (66) 66
Dissertation (30) 30
Web Resource (21) 21
Government Document (8) 8
Reference (4) 4
Paper (3) 3
Report (2) 2
Data Set (1) 1
Presentation (1) 1
Transcript (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (23919) 23919
humans (22031) 22031
male (11557) 11557
female (10931) 10931
proton pump inhibitors (8410) 8410
middle aged (8173) 8173
adult (6598) 6598
aged (6287) 6287
gastroenterology & hepatology (4657) 4657
treatment outcome (4483) 4483
surgery (4201) 4201
proton pump inhibitors - therapeutic use (3652) 3652
pharmacology & pharmacy (3611) 3611
animals (3499) 3499
mechanical engineering (3386) 3386
heating (3357) 3357
lighting (3348) 3348
weapons (3348) 3348
blasting (3346) 3346
hygiene (3320) 3320
human necessities (3316) 3316
medical or veterinary science (3310) 3310
abridged index medicus (2992) 2992
positive displacement machines for liquids (2791) 2791
pumps for liquids or elastic fluids (2791) 2791
risk factors (2761) 2761
therapy (2625) 2625
omeprazole (2600) 2600
infusion pumps (2464) 2464
care and treatment (2404) 2404
gastroesophageal reflux - drug therapy (2361) 2361
cardiac & cardiovascular systems (2337) 2337
pumps (2239) 2239
diagnosis (2219) 2219
adolescent (2142) 2142
retrospective studies (2057) 2057
infusion pumps, implantable (2055) 2055
proton pump inhibitor (2034) 2034
helicobacter pylori (2019) 2019
time factors (1984) 1984
helicobacter infections - drug therapy (1954) 1954
health aspects (1938) 1938
gastroesophageal reflux (1932) 1932
aged, 80 and over (1889) 1889
drug therapy, combination (1869) 1869
medicine, general & internal (1848) 1848
medicine & public health (1834) 1834
research (1750) 1750
analysis (1745) 1745
prospective studies (1702) 1702
drug therapy (1700) 1700
management (1695) 1695
anti-ulcer agents - therapeutic use (1615) 1615
child (1585) 1585
radiation therapy (1575) 1575
electrotherapy (1549) 1549
magnetotherapy (1549) 1549
ultrasound therapy (1549) 1549
rotary-piston, or oscillating-piston, positive-displacementmachines for liquids (1521) 1521
rotary-piston, or oscillating-piston, positive-displacementpumps (1521) 1521
endocrinology & metabolism (1516) 1516
lansoprazole (1419) 1419
proton pump inhibitors - adverse effects (1403) 1403
usage (1387) 1387
risk (1377) 1377
follow-up studies (1333) 1333
artificial respiration (1330) 1330
massage (1326) 1326
bathing devices for special therapeutic or hygienic purposesor specific parts of the body (1320) 1320
physical therapy apparatus, e.g. devices for locating orstimulating reflex points in the body (1320) 1320
young adult (1310) 1310
drug administration schedule (1292) 1292
identification (1281) 1281
children (1273) 1273
diabetes (1267) 1267
proton pump inhibitors - administration & dosage (1260) 1260
disease (1255) 1255
anti-bacterial agents - therapeutic use (1246) 1246
oncology (1205) 1205
insulin (1204) 1204
omeprazole - therapeutic use (1203) 1203
diabetes mellitus, type 1 - drug therapy (1184) 1184
pump (1141) 1141
microbiology (1136) 1136
dose-response relationship, drug (1130) 1130
insulin - administration & dosage (1130) 1130
rats (1094) 1094
gastroesophageal-reflux disease (1075) 1075
pediatrics (1068) 1068
internal medicine (1060) 1060
mortality (1054) 1054
double-blind (1042) 1042
respiratory system (1035) 1035
cancer (1033) 1033
dosage and administration (1030) 1030
infection (1029) 1029
gastroesophageal reflux disease (998) 998
metaanalysis (973) 973
patients (965) 965
type 1 diabetes (959) 959
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (28) 28
Online Resources - Online (21) 21
Scarborough Hospital - General (4) 4
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
Markham Stouffville Hospital - Stacks (2) 2
Scarborough Hospital - Birchmount (2) 2
Baycrest Hospital - Stacks (1) 1
Credit Valley Hospital - Missing (1) 1
Gerstein Science - Theses (1) 1
Humber River Regional Hospital - Finch Stacks (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Pharmacy (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
Toronto East General Hospital - Stacks (1) 1
Trillium Health Centre - Stacks (1) 1
West Park Healthcare Centre - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (32285) 32285
French (1357) 1357
German (1197) 1197
Japanese (941) 941
Chinese (376) 376
Russian (277) 277
Spanish (275) 275
Korean (254) 254
Polish (80) 80
Portuguese (70) 70
Italian (67) 67
Danish (40) 40
Dutch (37) 37
Hungarian (34) 34
Swedish (24) 24
Czech (22) 22
Norwegian (16) 16
Hebrew (15) 15
Finnish (14) 14
Turkish (9) 9
Romanian (8) 8
Ukrainian (8) 8
Croatian (5) 5
Serbian (4) 4
Bulgarian (3) 3
Greek (2) 2
Lithuanian (2) 2
Slovak (2) 2
Bosnian (1) 1
Icelandic (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Effect of Sensor-Augmented Insulin Pump Therapy and Automated Insulin Suspension vs Standard Insulin Pump Therapy on Hypoglycemia in Patients With Type 1 Diabetes: A Randomized Clinical Trial
by Ly, Trang T and Nicholas, Jennifer A and Retterath, Adam and Lim, Ee Mun and Davis, Elizabeth A and Jones, Timothy W
JAMA, ISSN 0098-7484, 09/2013, Volume 310, Issue 12, pp. 1240 - 1247
IMPORTANCE Hypoglycemia is a critical obstacle to the care of patients with type 1 diabetes. Sensor-augmented insulin pump with automated low-glucose insulin... 
RESPONSES | MEDICINE, GENERAL & INTERNAL | REDUCTION | ADOLESCENTS | IDDM | ADULTS | RISK | AWARENESS | DURATION | CHILDREN | Humans | Middle Aged | Child, Preschool | Insulin - administration & dosage | Male | Treatment Outcome | Diabetes Mellitus, Type 1 - drug therapy | Blood Glucose - drug effects | Young Adult | Hypoglycemic Agents - administration & dosage | Adolescent | Adult | Female | Insulin Infusion Systems | Hypoglycemia - chemically induced | Child | Hypoglycemic Agents - adverse effects | Insulin - adverse effects | Diabetic Ketoacidosis - chemically induced | Therapy | Pumps | Clinical trials | Diabetes | Hypoglycemia | Insulin | Patients | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Randomised clinical trial: comparative study of 10‐day sequential therapy with 7‐day standard triple therapy for Helicobacter pylori infection in naïve patients
by Park, H. G and Jung, M. K and Jung, J. T and Kwon, J. G and Kim, E. Y and Seo, H. E and Lee, J. H and Yang, C. H and Kim, E. S and Cho, K. B and Park, K. S and Lee, S. H and Kim, K. O and Jeon, S. W
Alimentary Pharmacology & Therapeutics, ISSN 0269-2813, 01/2012, Volume 35, Issue 1, pp. 56 - 65
Background The eradication rates following standard triple therapy for Helicobacter pylori infection are declining worldwide. Recent studies have shown that... 
METAANALYSIS | MANAGEMENT | EFFICACY | ERADICATION RATES | PROTON-PUMP INHIBITOR | KOREAN PATIENTS | PHARMACOLOGY & PHARMACY | QUADRUPLE | GASTROENTEROLOGY & HEPATOLOGY | ANTIMICROBIAL RESISTANCE | FAILURE | CONSENSUS REPORT | Humans | Middle Aged | Male | Rabeprazole | Peptic Ulcer - microbiology | Time Factors | Helicobacter Infections - drug therapy | Clarithromycin - administration & dosage | Metronidazole - adverse effects | Adult | Female | Amoxicillin - administration & dosage | Anti-Bacterial Agents - adverse effects | Drug Therapy, Combination | Republic of Korea | Drug Administration Schedule | 2-Pyridinylmethylsulfinylbenzimidazoles - adverse effects | Clarithromycin - adverse effects | Metronidazole - administration & dosage | Anti-Ulcer Agents - adverse effects | Endoscopy, Gastrointestinal | Treatment Outcome | Anti-Ulcer Agents - administration & dosage | Amoxicillin - adverse effects | Aged | Helicobacter pylori - isolation & purification | 2-Pyridinylmethylsulfinylbenzimidazoles - administration & dosage | Anti-Bacterial Agents - administration & dosage | Peptic Ulcer - drug therapy | Helicobacter Infections - microbiology | Medical colleges | Medical research | Clinical trials | Standards | Helicobacter pylori | Amoxicillin | Medicine, Experimental | Medical care | Helicobacter infections | Comparative analysis | Health aspects | Quality management | Infection | Clarithromycin | Hospitals | Metronidazole | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of Helicobacter pylori in the community and hospital populations: a randomised trial
by Liou, Jyh-Ming and Chen, Chieh-Chang and Chang, Chi-Yang and Chen, Mei-Jyh and Chen, Chien-Chuan and Fang, Yu-Jen and Lee, Ji-Yuh and Yang, Tsung-Hua and Luo, Jiing-Chyuan and Wu, Jeng-Yih and Liou, Tai-Cherng and Chang, Wen-Hsiung and Hsu, Yao-Chun and Tseng, Cheng-Hao and Chang, Chun-Chao and Bair, Ming-Jong and Liu, Tzeng-Ying and Hsieh, Chun-Fu and Tsao, Feng-Yun and Shun, Chia-Tung and Lin, Jaw-Town and Lee, Yi-Chia and Wu, Ming-Shiang and Taiwan Gastrointestinal Dis and Taiwan Gastrointestinal Disease and Helicobacter Consortium
Gut, ISSN 0017-5749, 11/2016, Volume 65, Issue 11, pp. 1784 - 1792
ObjectiveSignificant heterogeneity was observed in previous trials that assessed the efficacies of sequential therapy for 10 days (S10) versus triple therapy... 
MULTICENTER | METAANALYSIS | MANAGEMENT | EFFICACY | DRUG THERAPY | RESISTANCE | INFECTION | GASTROENTEROLOGY & HEPATOLOGY | Humans | Hospitalization - statistics & numerical data | Helicobacter pylori - drug effects | Male | Drug Monitoring - methods | Proton Pump Inhibitors - administration & dosage | Helicobacter Infections - drug therapy | Clarithromycin - administration & dosage | Metronidazole - adverse effects | Adult | Female | Amoxicillin - administration & dosage | Anti-Bacterial Agents - adverse effects | Helicobacter Infections - diagnosis | Lansoprazole - administration & dosage | Proton Pump Inhibitors - adverse effects | Drug Administration Schedule | Clarithromycin - adverse effects | Metronidazole - administration & dosage | Treatment Outcome | Drug Therapy, Combination - methods | Lansoprazole - adverse effects | Amoxicillin - adverse effects | Ambulatory Care - statistics & numerical data | Helicobacter pylori - isolation & purification | Anti-Bacterial Agents - administration & dosage | Breath Tests - methods | Helicobacter Infections - microbiology | Hospital patients | Care and treatment | Usage | Helicobacter pylori | Therapeutics | Research | Health aspects | Homeopathy | Materia medica and therapeutics | Index Medicus | Abridged Index Medicus | Helicobacter Pylori | HELICOBACTER PYLORI - TREATMENT | 1506 | ANTIBIOTIC THERAPY
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text High dose dual therapy versus bismuth quadruple therapy for Helicobacter pylori eradication treatment: A systematic review and meta-analysis
by Yang, Xue and Wang, Jin-Xia and Han, Sheng-Xi and Gao, Cai-Ping
Medicine, ISSN 0025-7974, 02/2019, Volume 98, Issue 7, pp. e14396 - e14396
Aim: The aim of this study was to perform a systematic review and meta-analysis on high-dose dual therapy (HDDT) versus bismuth quadruple therapy (BQT) for... 
1ST-LINE TREATMENT | DUODENAL-ULCER | meta-analysis | ANTIBIOTIC-RESISTANCE | RANDOMIZED-TRIAL | TREATMENT OPTION | AMOXICILLIN | bismuth quadruple therapy | NON-INFERIORITY | MEDICINE, GENERAL & INTERNAL | Helicobacter pylori | high dose dual therapy | DOUBLE-BLIND | TRIPLE THERAPY | RESCUE THERAPY | Anti-Bacterial Agents - therapeutic use | Bismuth - administration & dosage | Drug Administration Schedule | Proton Pump Inhibitors - administration & dosage | Helicobacter Infections - drug therapy | Humans | Bismuth - therapeutic use | Drug Therapy, Combination | Proton Pump Inhibitors - therapeutic use | Anti-Bacterial Agents - administration & dosage | Randomized Controlled Trials as Topic | Helicobacter infections | Drug therapy, Combination | Comparative analysis | Drug therapy | Methods | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Ten‐day triple therapy versus sequential therapy versus concomitant therapy as first‐line treatment for Helicobacter pylori infection
by Ang, Tiing Leong and Fock, Kwong Ming and Song, Mingjun and Ang, Daphne and Kwek, Andrew Boon Eu and Ong, Jeannie and Tan, Jessica and Teo, Eng Kiong and Dhamodaran, Subbiah
Journal of Gastroenterology and Hepatology, ISSN 0815-9319, 07/2015, Volume 30, Issue 7, pp. 1134 - 1139
Background and AimClarithromycin-based triple therapy (TT) is the first-line treatment for Helicobacter pylori infection in Singapore. There is awareness that... 
treatment | antibiotic resistance | pylori | H.pylori | Treatment | Antibiotic resistance | ANTIMICROBIAL SUSCEPTIBILITY | CLARITHROMYCIN | METAANALYSIS | ANTIBIOTIC-RESISTANCE | RANDOMIZED-TRIAL | OPEN-LABEL | GASTRIC-CANCER | PROTON PUMP INHIBITOR | PACIFIC CONSENSUS GUIDELINES | ERADICATION | GASTROENTEROLOGY & HEPATOLOGY | Gastritis - drug therapy | Prospective Studies | Humans | Metronidazole - administration & dosage | Middle Aged | Drug Resistance, Bacterial | Helicobacter pylori - drug effects | Male | Treatment Outcome | Helicobacter Infections | Metronidazole - pharmacology | Young Adult | Proton Pump Inhibitors - administration & dosage | Amoxicillin - pharmacology | Clarithromycin - administration & dosage | Adult | Female | Amoxicillin - administration & dosage | Anti-Bacterial Agents - pharmacology | Anti-Bacterial Agents - administration & dosage | Clarithromycin - pharmacology | Urea | Helicobacter infections | Care and treatment | Helicobacter pylori | Health aspects | Amoxicillin | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Modified Sequential Helicobacter pylori Therapy: Proton Pump Inhibitor and Amoxicillin for 14 Days with Clarithromycin and Metronidazole added as a Quadruple (Hybrid) Therapy for the Final 7 Days
by Hsu, Ping‐I and Wu, Deng‐Chyang and Wu, Jeng‐Yih and Graham, David Y
Helicobacter, ISSN 1083-4389, 04/2011, Volume 16, Issue 2, pp. 139 - 145
Background:  Ten‐day sequential therapy with a proton pump inhibitor (PPI) and amoxicillin followed by a PPI, clarithromycin, and an imidazole typically... 
sequential therapy | clinical trial | amoxicillin | metronidazole | clarithromycin | Helicobacter pylori | RANDOMIZED CONTROLLED-TRIALS | METAANALYSIS | MANAGEMENT | ANTIBIOTIC-RESISTANCE | MICROBIOLOGY | ISSUES | TRIPLE THERAPY | INFECTION | ERADICATION | GASTROENTEROLOGY & HEPATOLOGY | Drug Administration Schedule | Humans | Middle Aged | Male | Treatment Outcome | Clarithromycin - therapeutic use | Proton Pump Inhibitors - therapeutic use | Anti-Bacterial Agents - therapeutic use | Metronidazole - therapeutic use | Helicobacter Infections - drug therapy | Amoxicillin - therapeutic use | Adult | Female | Aged | Drug Therapy, Combination | Medical colleges | Care and treatment | Clarithromycin | Amoxicillin | Helicobacter infections | Antiulcer drugs | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Personalized therapy for Helicobacter pylori: CYP2C19 genotype effect on first-line triple therapy
by Arévalo Galvis, Azucena and Trespalacios Rangel, Alba Alicia and Otero Regino, William
Helicobacter, ISSN 1083-4389, 06/2019, Volume 24, Issue 3, pp. e12574 - e12574
BackgroundTriple therapy efficacy against Helicobacter pylori is low worldwide, and thus, alternatives must be sought to improve eradication. The aim of the... 
CYP2C19 | H pylori | personalized therapy | GENETIC-POLYMORPHISM | CURE RATES | ANTIBIOTIC-RESISTANCE | OMEPRAZOLE | MICROBIOLOGY | POLYMORPHISM INFLUENCES | Hpylori | CYTOCHROME P2C19 | CYP2C19-ASTERISK-17 ALLELE | PROTON PUMP INHIBITOR | ERADICATION THERAPY | INFECTION | GASTROENTEROLOGY & HEPATOLOGY | Omeprazole | Care and treatment | Helicobacter pylori | Cytochrome P-450 | Amoxicillin | Helicobacter infections | Genetic aspects | Bacterial genetics | Genetic polymorphisms | Antigens | Therapy | Clarithromycin | Randomization | Effectiveness | Antibiotics | Gene polymorphism | Polymorphism
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Consensus document: Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: A North-American perspective
by Faxon, David P and Eikelboom, John W and Berger, Peter B and Holmes, David R and Bhatt, Deepak L and Moliterno, David J and Becker, Richard C and Angiolillo, Dominick J
Thrombosis and Haemostasis, ISSN 0340-6245, 10/2011, Volume 106, Issue 4, pp. 572 - 584
The optimal regimen of the anticoagulant and antiplatelet therapies in patients with atrial fibrillation who have had a coronary stent is unclear. It is well... 
Warfarin | Antithrombotic therapy | Stent | Triple therapy | Atrial fibrillation | stent | ELUTING STENT | ORAL ANTICOAGULANT | MYOCARDIAL-INFARCTION | BARE-METAL | antithrombotic therapy | PROTON-PUMP INHIBITORS | warfarin | triple therapy | DUAL ANTIPLATELET THERAPY | LOW-DOSE ASPIRIN | ACCF/AHA/HRS FOCUSED UPDATE | RHYTHM ASSOCIATION EHRA | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | CARDIOLOGY WORKING GROUP | Atrial Fibrillation - drug therapy | Humans | Atrial Fibrillation - complications | Stents - utilization | Warfarin - adverse effects | Risk | Atrial Fibrillation - surgery | Consensus Development Conferences as Topic | North America | Warfarin - administration & dosage | Drug Therapy, Combination - adverse effects | Thrombosis - etiology | Hemorrhage - etiology | Platelet Aggregation Inhibitors - administration & dosage | Coronary Vessels - surgery | Thrombosis - prevention & control | Postoperative Complications | Blood Vessel Prosthesis Implantation | Platelet Aggregation Inhibitors - adverse effects
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Proton-Pump Inhibitor Therapy Induces Acid-Related Symptoms in Healthy Volunteers After Withdrawal of Therapy
by Reimer, Christina and Søndergaard, Bo and Hilsted, Linda and Bytzer, Peter
Gastroenterology, ISSN 0016-5085, 2009, Volume 137, Issue 1, pp. 80 - 87.e1
Background & Aims Rebound acid hypersecretion (RAHS) has been demonstrated after 8 weeks of treatment with a proton-pump inhibitor (PPI). If RAHS induces... 
Gastroenterology and Hepatology | CONTROLLED TRIAL | PRIMARY-CARE | HYPERSECRETION | DUODENAL-ULCER | OMEPRAZOLE | CHROMOGRANIN-A | SECRETION | RATING-SCALE | GASTROENTEROLOGY & HEPATOLOGY | CELL | DYSPEPSIA | Esomeprazole - administration & dosage | Humans | Middle Aged | Esomeprazole - adverse effects | Male | Reference Values | Dyspepsia - chemically induced | Heartburn - chemically induced | Gastroesophageal Reflux - chemically induced | Young Adult | Gastric Acid - secretion | Proton Pump Inhibitors - administration & dosage | Time Factors | Gastric Mucosa - drug effects | Adult | Female | Severity of Illness Index | Proton Pump Inhibitors - adverse effects | Gastroesophageal Reflux - metabolism | Double-Blind Method | Drug Administration Schedule | Treatment Outcome | Dyspepsia - metabolism | Gastric Mucosa - secretion | Adolescent | Heartburn - metabolism | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Nonbismuth Quadruple (Concomitant) Therapy: Empirical and Tailored Efficacy versus Standard Triple Therapy for Clarithromycin‐Susceptible Helicobacter pylori and versus Sequential Therapy for Clarithromycin‐Resistant Strains
by Molina‐Infante, Javier and Pazos‐Pacheco, Carmen and Vinagre‐Rodriguez, Gema and Perez‐Gallardo, Belen and Dueñas‐Sadornil, Carmen and Hernandez‐Alonso, Moisés and Gonzalez‐Garcia, Guadalupe and Mateos‐Rodriguez, Jose M and Fernandez‐Bermejo, Miguel and Gisbert, Javier P
Helicobacter, ISSN 1083-4389, 08/2012, Volume 17, Issue 4, pp. 269 - 276
Background:  Using quadruple clarithromycin‐containing regimens for Helicobacter pylori eradication is controversial with high rates of macrolide resistance.... 
sequential therapy | concomitant therapy | Helicobacter pylori | nonbismuth quadruple therapy | triple therapy | clarithromycin resistance | Sequential therapy | Nonbismuth quadruple therapy | Concomitant therapy | Triple therapy | Clarithromycin resistance | METAANALYSIS | MANAGEMENT | ANTIBIOTIC-RESISTANCE | RANDOMIZED-TRIAL | MICROBIOLOGY | REGIMENS | 4-DRUG | LEVOFLOXACIN | ERADICATION THERAPY | INFECTION | METRONIDAZOLE | GASTROENTEROLOGY & HEPATOLOGY | Humans | Middle Aged | Drug Resistance, Bacterial | Helicobacter pylori - drug effects | Male | Clarithromycin - therapeutic use | Proton Pump Inhibitors - therapeutic use | Young Adult | Anti-Bacterial Agents - therapeutic use | Metronidazole - therapeutic use | Helicobacter Infections - drug therapy | Adolescent | Amoxicillin - therapeutic use | Aged, 80 and over | Adult | Female | Aged | Helicobacter pylori - physiology | Drug Therapy, Combination | Helicobacter Infections - microbiology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text The efficacy of hybrid therapy as first‐line regimen for Helicobacter pylori infection compared with sequential therapy
by Oh, Dong Hyun and Lee, Dong Ho and Kang, Kyu Keun and Park, Young Soo and Shin, Cheol Min and Kim, Nayoung and Yoon, Hyuk and Hwang, Jin Hyeok and Jeoung, Sook Hyang and Kim, Jin Wook and Jang, Eun Sun and Jung, Hyun Chae
Journal of Gastroenterology and Hepatology, ISSN 0815-9319, 06/2014, Volume 29, Issue 6, pp. 1171 - 1176
Background and AimRecent prospective studies have shown that the sequential therapy has not achieved the target Helicobacter pylori eradication rate of >80% in... 
elicobacter pylori | sequential therapy | alternative therapies | hybrid therapy | disease eradication | Hybrid therapy | Helicobacter pylori | Sequential therapy | Disease eradication | Alternative therapies | CLARITHROMYCIN | METAANALYSIS | PREVALENCE | KOREA | AMOXICILLIN | STANDARD TRIPLE THERAPY | PROTON PUMP INHIBITOR | CONCOMITANT | RESISTANCE | ERADICATION | GASTROENTEROLOGY & HEPATOLOGY | Gastritis - drug therapy | Follow-Up Studies | Humans | Metronidazole - administration & dosage | Middle Aged | Male | Treatment Outcome | Helicobacter Infections - drug therapy | Clarithromycin - administration & dosage | Gastritis - microbiology | Female | Aged | Amoxicillin - administration & dosage | Helicobacter pylori - isolation & purification | Drug Therapy, Combination | Rabeprazole - administration & dosage | Urea | Helicobacter infections | Comparative analysis | Health aspects | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Therapy for Helicobacter pylori Infection Can be Improved: Sequential Therapy and Beyond
by Graham, David Y and Lu, Hong and Yamaoka, Yoshio
Drugs, ISSN 0012-6667, 2008, Volume 68, Issue 6, pp. 725 - 736
As with other bacterial infections, successful treatment of Helicobacter pylori infections depends on the use of antibacterial agents to which the organism is... 
Helicobacter pylori eradication therapies | Proton pump inhibitors | Clarithromycin | Helicobacter pylori infections | Amoxicillin | Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Helicobacter pylori eradication therapies, therapeutic use | Helicobacter pylori infections, treatment | Proton pump inhibitors, therapeutic use | Clarithromycin, therapeutic use | Amoxicillin, therapeutic use | UNITED-STATES | ANTIMICROBIAL SUSCEPTIBILITY | QUADRUPLE THERAPY | CYP2C19 POLYMORPHISM | DUAL THERAPY | PROTON-PUMP INHIBITOR | DOUBLE-BLIND | ANTIBIOTIC-RESISTANCE | CURE RATE | PHARMACOLOGY & PHARMACY | TOXICOLOGY | 7-DAY TRIPLE-THERAPY | Anti-Bacterial Agents - economics | Drug Costs | Proton Pump Inhibitors - economics | Drug Administration Schedule | Humans | Drug Resistance, Bacterial | Treatment Outcome | Clinical Trials as Topic | Helicobacter pylori | Proton Pump Inhibitors - administration & dosage | Cost-Benefit Analysis | Helicobacter Infections - drug therapy | Drug Therapy, Combination | Anti-Bacterial Agents - administration & dosage | Research Design | Helicobacter Infections - microbiology | Practice Guidelines as Topic | Usage | Patient outcomes | Helicobacter infections | Drug therapy, Combination | Drug therapy | Health aspects | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Continuation of low-dose aspirin therapy in peptic ulcer bleeding: A randomized trial
by Sung, Joseph J. Y and Lau, James Y. W and Ching, Jessica Y. L and Wu, Justin C. Y and Lee, Yuk T and Chiu, Philip W. Y and Leung, Vincent K. S and Wong, Vincent W. S and Chan, Francis K. L
Annals of Internal Medicine, ISSN 0003-4819, 01/2010, Volume 152, Issue 1, pp. 1 - 9
Background: It is uncertain whether aspirin therapy should be continued after endoscopic hemostatic therapy in patients who develop peptic ulcer bleeding while... 
MEDICINE, GENERAL & INTERNAL | MANAGEMENT | CLOPIDOGREL | TASK-FORCE | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | HEMORRHAGE | ANTITHROMBOTIC THERAPY | GUIDELINES | AMERICAN-COLLEGE | RISK | OUTCOMES | Recurrence | Cardiovascular Diseases - prevention & control | Humans | Male | Aspirin - administration & dosage | Cerebrovascular Disorders - prevention & control | Aspirin - adverse effects | 2-Pyridinylmethylsulfinylbenzimidazoles - therapeutic use | Platelet Aggregation Inhibitors - administration & dosage | Aged, 80 and over | Gastrointestinal Hemorrhage - therapy | Female | Drug Therapy, Combination | Platelet Aggregation Inhibitors - adverse effects | Anti-Ulcer Agents - therapeutic use | Double-Blind Method | Drug Administration Schedule | Risk Factors | Endoscopy, Gastrointestinal | Proton Pump Inhibitors - therapeutic use | Gastrointestinal Hemorrhage - chemically induced | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Peptic Ulcer - therapy | Hemostatic Techniques | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage | Aged | Peptic Ulcer - chemically induced | Complications and side effects | Aspirin | Peptic ulcer | Dosage and administration | Research | Drug therapy | Hemorrhage | Risk factors | Clinical trials | Ulcers | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow